Statin News and Research

RSS

Statins are drugs used to lower cholesterol. Your body needs some cholesterol to work properly. But if you have too much in your blood, it can stick to the walls of your arteries, narrowing or even blocking them.

Updated guidelines for treatment of blood cholesterol

The National Cholesterol Education Program (NCEP) has updated its guidelines for treatment of blood cholesterol, suggesting that people at risk for heart attack and stroke would benefit from more intensive cholesterol-lowering therapies.

13 Jul 2004

New guidelines for treating heart attacks

If your chest pain worsens and lasts more than five minutes, especially if you’re short of breath, feel weak, nauseated or lightheaded, call 9-1-1—you could be having a heart attack.

8 Jul 2004

Mediterranean diet lowers levels of markers for inflammation and coagulation which have been linked to heart disease

“The benefits of this diet are very well known, but the mechanism is not well understood. We believe this is the first time it has been reported that the potential mechanism goes through the inflammation process,” said Demosthenes B. Panagiotakos, MSc, PhD with Harokopio University in Athens, Greece.

7 Jul 2004

Nearly 50 million U.S. adults have hypertension, more than two-thirds of them also have high cholesterol

People who have high blood pressure are highly likely to also have untreated or insufficiently treated cholesterol problems that significantly increase their risk for heart attack and stroke

29 Jun 2004

Possible association between the cholesterol lowering drug Crestor, and a serious condition called rhabdomyolysis

Health Canada is advising Canadians about a possible association between the cholesterol lowering drug Crestor®, and a serious condition called rhabdomyolysis.

23 Jun 2004

Statins could be effective in relieving symptoms of rheumatoid arthritis

Results of a UK study in this week's issue of THE LANCET suggest that the anti-inflammatory effect of statins (a class of cholesterol-lowering drugs) could be effective in relieving symptoms of rheumatoid arthritis.

17 Jun 2004

Heart attack patients are discharged without evidenced-based, guideline recommended, life-prolonging therapies

Heart attack care is more likely to match recommended guidelines when health care providers use standardized forms and other reminders, and institutional systems reinforce goals for treatment and patient lifestyles, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.

16 Jun 2004

Statins don't always lower cholesterol

Persons with certain genetic variations who take statins to lower their cholesterol will not realize the same benefit as other individuals, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).

15 Jun 2004

Cholesterol lowering medications may reduce risk of glaucoma

Long-term use of statins, medications commonly prescribed to lower cholesterol, may be associated with a reduced risk of glaucoma among patients with cardiovascular diseases and high cholesterol, according to an article in the June issue of the Archives of Ophthalmology, one of the JAMA/Archives journals.

15 Jun 2004

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University Cancer Institute researchers.

9 Jun 2004

Treatment with atorvastatin cut incidence of stroke by almost a half

Patients with Type 2 diabetes and a CV risk factor would benefit from a cholesterol-lowering medicine according to results from the first ever specifically designed UK primary prevention statin trial announced today at the American Diabetes Association (ADA)2.

7 Jun 2004

New advice to doctors on lowering diabetes-heart disease risks

Every year, the American Diabetes Association (ADA) issues Clinical Practice Recommendations, a series of updated recommendations, to help health care providers treat people with diabetes using the most current research available.

5 Jun 2004

Statins should not be considered as a stand-alone wonder-drug in the fight against heart disease

Dr John Reid, the Health Secretary for the United Kingdom (UK), announced the reclassification of statins as ‘over the counter’ products in the UK, to be available to members of the public directly from pharmacists without the need for a prescription.

17 May 2004

Cholesterol-lowering drugs could treat multiple sclerosis

Drug treatments for MS are expensive and only partially effective. Recent knowledge that statins promote an anti-inflammatory response from the immune system suggest a potential in the treatment of MS.

13 May 2004

Heart drug simvastatin will be available without a prescription

People will be able to get a drug that can reduce the risk of heart attacks without a prescription from this summer, the government announced today.

12 May 2004

Zocor Heart Pro to be available over the counter

Ministers have accepted the advice of the Committee on Safety of Medicines (CSM) that simvastatin 10mg (Zocor Heart Pro) could be safely sold through pharmacies to reduce the risk of a first major coronary event in people likely to be at a moderate risk of coronary heart disease (CHD).

12 May 2004

Measurable improvements in productivity throughout the NHS

NHS Chief Executive, Sir Nigel Crisp today reported that sustained improvements to services for patients were being accelerated, with measurable improvements in productivity throughout the NHS.

8 May 2004

Study shows Chromium Picolinate and Biotin Combination significantly lowers coronary risk factors in people with Type 2 Diabetes

Results of a new double-blind, placebo-controlled, randomized clinical study show that daily nutritional supplementation with a combination of chromium picolinate and biotin (marketed as Diachromeä) significantly improved coronary risk factors in people with type 2 diabetes.

6 May 2004

Cholesterol-lowering statin products may be the next class of drugs to go over the counter

Cholesterol-lowering statin products may be the next class of drugs to go over the counter (OTC), according to "Cardiovascular Marketing," a new study by business intelligence firm Cutting Edge Information.

28 Apr 2004

Test results from 1970s linked to rates of erectile problems 25 years later

Age, obesity, high cholesterol, and high triglyceride measurements in midlife predict not only heart disease risks, but also the likelihood of erectile dysfunction decades later, according to a new study in the April 21, 2004 issue of the Journal of the American College of Cardiology.

20 Apr 2004